Latest Mesoblast (ASX:MSB) News
Page 1
Page 1 of 5
Healthcare Wrap - Week 44 (26 Oct -> 30 Oct) 2026
31 Oct 2026
Mesoblast clears FDA path as Ryoncil revenue rises and pain trial reaches key milestone
29 Oct 2026
Market Wrap - Week 42 (12 Oct -> 16 Oct) 2026
17 Oct 2026
Healthcare Wrap - Week 42 (12 Oct -> 16 Oct) 2026
17 Oct 2026
Mesoblast Ryoncil revenue jumps 44% as quarterly cash spend falls to US$2.3 million
16 Oct 2026
Healthcare Wrap - Week 39 (21 Sept -> 25 Sept) 2026
26 Sept 2026
Mesoblast wins FDA clearance for new Ryoncil potency test
24 Sept 2026
Healthcare Wrap - Week 34 (17 Aug -> 21 Aug) 2026
22 Aug 2026
Mesoblast Completes Treatment in Pivotal Phase 3 Trial for Chronic Low Back Pain
17 Aug 2026
Healthcare Wrap - Week 31 (27 July -> 31 July) 2026
1 Aug 2026
Mesoblast Posts US$115M Ryoncil Revenue as Adult Trials and CAR Tech Advance
30 July 2026